LDL-mediated chemoresistance to Lapatinib involves dysregulation of CYP3A4, SULT1A1, and HER2 signaling in HER2+ breast cancer
Development of a more penetrating HER2-positive Breast Cancer Tumor Model and Testing Efficacy of SHP2 Targeting with an Active-Site Inhibitor
A p53 peptide mucosal vaccine induces cellular and humoral immunity and anti-tumor effects in a murine colorectal cancer model
Exploration of the Mechanism of Anlotinib in Reversing PD-1 Immunotherapy Resistance: Insights from Single-cell Sequencing
Landscape and functional impact of missense mutations of immune response genes in human cancer
FXYD5 promotes the growth of glioblastoma by targeting the PI3K/AKT/ACSL4 signaling axis
Characteristics and Developmental Trajectory of Clinical Trials Focused on Tumor-Infiltrating Lymphocytes for Cancer Treatment
Activating NRF2E79Q mutation alters the differentiation of human non-small cell lung cancer
Paricalcitol and hydroxychloroquine modulates extracellular matrix and enhance chemotherapy efficacy in pancreatic cancer
New insights into the classification of the RAC1 P29S hotspot mutation in melanoma as an oncogene